BUZZ-CRISPR Therapeutics soars to fresh record after upsized stock offering

(Updates stock activity, adds deal color)

** CRISPR Therapeutics (Frankfurt: 1CG.F - news) shares reverse premarket losses and soar to new record high after co's upsized equity raise

** Stock jumps as much as 19.2 pct to $28.499 on Fri; has traded over 3 mln shares, its busiest day ever

** Swiss gene editing biotech prices 5 mln shares at $22.75, a 4.9 pct discount to stock's Thurs close

** Raises $113.8 mln vs $100 mln targeted upon deal launch

** Underwriters Goldman Sachs, Piper, Barclays (LSE: BARC.L - news) and Guggenheim said offering attracted new investors, though existing holders anchored the deal, according to IFR

** VC-backer Versant Ventures was No. 1 holder with 18.5 pct pre-offer stake, followed by Bayer (Swiss: BAYN-EUR.SW - news) (12.5 pct), Celgene (8 pct), New Enterprise (7.9 pct), GlaxoSmithKline (Amsterdam: GO8.AS - news) (7.9 pct) and Vertex Pharmaceuticals (6.7 pct)

** CRISPR went public in Oct (Shenzhen: 000069.SZ - news) 2016 at $14/sh in an IPO that was priced to move